24-Apr-2024
TipRanks (Thu, 25-Apr 7:10 AM ET)
Encompass Health’s Growth Trajectory Spurs Buy Rating and Increased Price Objective
TipRanks (Thu, 25-Apr 7:05 AM ET)
Encompass Health Enhances Investor Insights with Adjusted Financials
TipRanks (Wed, 24-Apr 4:44 PM ET)
Encompass Health Non-GAAP EPS of $1.12 beats by $0.18, revenue of $1.32B beats by $50M
Seeking Alpha News (Wed, 24-Apr 4:29 PM ET)
Encompass Health reports results for first quarter 2024
PRNewswire (Wed, 24-Apr 4:15 PM ET)
Notable earnings after Wednesday's close
Seeking Alpha News (Tue, 23-Apr 5:35 PM ET)
Encompass Health Q1 2024 Earnings Preview
Seeking Alpha News (Tue, 23-Apr 5:20 PM ET)
Encompass Health announces date of 2024 first quarter earnings call
PRNewswire (Wed, 10-Apr 4:30 PM ET)
PRNewswire (Wed, 3-Apr 4:30 PM ET)
Encompass Health announces annual stockholder meeting date
PRNewswire (Tue, 2-Apr 4:30 PM ET)
Encompass Health Corp provides post-acute healthcare services in the United States through a network of inpatient rehabilitation hospitals. Inpatient rehabilitation contributes the majority of the firm's revenue and provides specialized rehabilitative treatment through a network of inpatient hospitals. These hospitals are concentrated in the eastern half of the United States and Texas.
Encompass Health trades on the NYSE stock market under the symbol EHC.
As of April 24, 2024, EHC stock price climbed to $82.80 with 1,136,103 million shares trading.
EHC has a beta of 0.63, meaning it tends to be less sensitive to market movements. EHC has a correlation of 0.15 to the broad based SPY ETF.
EHC has a market cap of $8.26 billion. This is considered a Mid Cap stock.
Last quarter Encompass Health reported $1 billion in Revenue and $.95 earnings per share. This beat revenue expectation by $7 million and exceeded earnings estimates by $.13.
In the last 3 years, EHC stock traded as high as $89.11 and as low as $44.33.
The top ETF exchange traded funds that EHC belongs to (by Net Assets): VTI, IJH, VB, VBR, VXF.
EHC has outperformed the market in the last year with a price return of +31.2% while the SPY ETF gained +24.1%. EHC has also outperformed the stock market ETF in the last 3 month and 2 week periods returning +17.6% and +1.5%, respectively, while the SPY returned +4.5% and -1.7%, respectively.
EHC support price is $81.28 and resistance is $83.64 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that EHC stock will trade within this expected range on the day.